Company / SG&A Expense
Acadia Healthcare SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$177.6M
FY2025
5-year range
$90.4M / $177.6M
FY2021-FY2025
Trend
+13.3%
vs FY2024
Sector context
#114 of 158
Health Care
What the data says
At $178M, Acadia Healthcare's sg&a expense ranks #45 of 158 in the Health Care sector. SG&A Expense has increased for 5 consecutive years, from $87M in FY2020 to $178M in FY2025.
Based on SEC 10-K filings.
$178M in FY2025 with a 5-year CAGR of +15.4%.
Increased from $153M to $178M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +22.0%
- 5-Year CAGR
- +15.4%
- 10-Year CAGR
- -
Sector benchmark
#45 of 158 in Health CareTop 28% of 158This company $177.6M Sector average $175.9B
▼
-99.9% below sector average
Key checks
Key Insights
- Acadia Healthcare's sg&a expense has grown for 5 consecutive years.
- 5-year CAGR of +15.4%, indicating consistent growth.
- In FY2025, sg&a expense increased 13.3% year-over-year.
- Ranks #114 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.75 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $177.6M | +13.3% |
| FY2024 | $156.8M | +2.3% |
| FY2023 | $153.3M | +56.7% |
| FY2022 | $97.8M | +8.2% |
| FY2021 | $90.4M | +4.4% |
| FY2020 | $86.6M | -4.2% |
| FY2019 | $90.4M | +4.4% |
| FY2018 | $86.6M | +13.4% |
| FY2017 | $76.4M | -12.0% |
| FY2016 | $86.8M | +27.1% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026